Inflammatory disorders

FDA approves Wezlana for multiple inflammatory diseases

The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.

Medications

Using a CBD product? Be sure to tell your doctor

Cannabinoid products may interfere with some prescription medications, so people who use them should add these to the list of supplements they tell their doctors about.

page 2 from 29